EQUAMIRA Trademark

Trademark Overview

On Friday, January 24, 2020, a trademark application was filed for EQUAMIRA with the United States Patent and Trademark Office. The USPTO has given the EQUAMIRA trademark a serial number of 88773060. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2023. This trademark is owned by COHERUS BIOSCIENCES, INC.. The EQUAMIRA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of autoimmune diseases
equamira

General Information

Serial Number88773060
Word MarkEQUAMIRA
Filing DateFriday, January 24, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCOHERUS BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressREDWOOD CITY, CA 94065
Party NameCOHERUS BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressREDWOOD CITY, CA 94065

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 1, 2022SOU EXTENSION 3 FILED
Wednesday, June 1, 2022TEAS EXTENSION RECEIVED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 2 GRANTED
Tuesday, November 30, 2021SOU EXTENSION 2 FILED
Tuesday, November 30, 2021TEAS EXTENSION RECEIVED
Thursday, May 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 25, 2021SOU EXTENSION 1 GRANTED
Tuesday, May 25, 2021SOU EXTENSION 1 FILED
Tuesday, May 25, 2021TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION E-MAILED
Monday, March 2, 2020NON-FINAL ACTION WRITTEN
Thursday, February 27, 2020ASSIGNED TO EXAMINER
Wednesday, January 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 28, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

equamira diseases autoimmune treatment preparations pharmaceutical